Evidence map›Paper›PMID 16378174›Full record

ArticleJournal of gastroenterology2005

The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms.

Giuseppe Riezzo, Caterina Clemente, Silvana Leo, Francesco Russo

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01244945 phase4completednot on this mapstarted 2011, after this paper: background citation

Effect of Lactobacillus Reuteri DSM 17938 on Gut Motility in Patients With Functional Constipation

TypeinterventionalSponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisRan2011 to 2014Enrolled72ConditionsFunctional ConstipationArmsL. reuteri DSM 17938, Placebo Group
NCT01382667 completednot on this mapstarted 2011, after this paper: background citation

Evaluation of Dyspeptic Symptoms in Oncological Frail Patients With Extraintestinal Cancer in Chemotherapy. Assessment of Circulating Levels of Glucagon-like Peptide 2 (GLP-2) in Relation to Mucositis

TypeobservationalSponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisRan2011 to 2012Enrolled70ConditionsBreast Cancer, Lung Cancer, Dyspepsia
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giuseppe RiezzoLaboratory of Experimental Pathophysiology S. de Bellis, National Institute for Digestive Diseases, Via F. Valente, 4, 70013 Castellana, Grotte (BA), Italy.
Caterina Clemente
Silvana Leo
Francesco Russo
Gastroenterology Hospital "Saverio de Bellis" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to investigate the relationship among motility disorders, dyspeptic symptoms, and plasma levels of gastrointestinal hormones in cancer patients who were well controlled for post-chemotherapy emesis.

methodsTwenty-five cancer patients treated with standard dosages of antiemetics and chemotherapies completed the study. Gastrointestinal symptoms were investigated by detailed questionnaire and visual analog score. Motility was investigated by cutaneous electrogastrography, and by blood levels of gastrin, serotonin, vasopressin, and substance P, before and 7 days after chemotherapy.

resultsBefore chemotherapy, no patient complained of dyspeptic symptoms, and no differences in electrogastrography (EGG) or in circulating peptide levels were found between patients who developed dyspepsia and those who did not. After chemotherapy, 13 patients suffered from dysmotility-like symptoms (total symptom score, 11.5 [2.5-37.9]; median value and 5th-95th percentiles), with susceptibility to nausea, early satiety, and postprandial fullness being the major complaints. As regards EGG parameters, a significant reduction (P = 0.04; Mann-Whitney test) in the normal slow-wave percentage and significantly increased tachygastria percentage were found in dyspeptic patients compared with symptom-free patients. The tachygastria percentage was significantly associated with susceptibility to nausea score, in a non-linear fashion (R2 = 0.37). Dyspeptic patients showed lower levels of substance P and gastrin than patients who were not dyspeptic, but this difference had no clinical significance for dyspepsia.

conclusionsChemotherapy may induce upper gastrointestinal symptoms suggestive of motility disorders. These dyspeptic symptoms were associated with EGG alterations, but not with variations in circulating peptides. Other hormones or pathophysiological factors, not considered in the present work, could be actively involved in these dyspeptic symptoms.

Indexed as

AgedAntineoplastic AgentsDyspepsiaElectrophysiologyFemaleGastrinsGastrointestinal HormonesGastrointestinal MotilityHumansMaleNeoplasmsSerotoninStomachSubstance PVasopressinsAntineoplastic AgentsGastrinsGastrointestinal HormonesSerotoninSubstance PVasopressins

Identifiers

PMID16378174
OpenAlexW2090014262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.